A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
RNAi Agents for Inhibiting Expression of Activin Receptor‑Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use
Patent Number: US 12,442,002 B2Filing Date: December 19, 2024Patent Issue Date: October 14, 2025Assignee: Arrowhead Pharmaceuticals, Inc. (Pasadena, CA, USA)Publication Family: WO/2025/137390 (published June 26, 2025) What This Patent Covers This U.S. patent covers RNA interference (RNAi) agents — including chemically modified small…
-
Methods and Processes for Non‑Invasive Assessment of Genetic Variations
Assignee: Sequenom, Inc.Patent Number: 12,437,838 B2Filed: October 25, 2019Issued: October 7, 2025Inventors: Cosmin Deciu, Zeljko DzakulaCategory: Genetic analysis / Non‑invasive diagnostics What This Patent Covers This patent protects methods and processes for non‑invasive assessment of genetic variations from biological samples…
-
Modified Vectors for XLA Gene Therapy
Patent Title: Modified Vectors for XLA Gene TherapyPublication Number: WO/2025/215591Application Number: PCT/IB2025/053804Filing Date: April 11, 2025Publication Date: October 16, 2025Applicants: CSL Behring L.L.C. & Seattle Children’s Hospital Research Institute What This Patent Covers This international…
BioTech IP Review 